Pharmaceutical company Mankind Pharma, the maker of popular condom brand Manforce, has filed its draft red herring prospectus DRHP with the Indian market regulator Securities and Exchange Board of India (SEBI).
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
